Diabetes Health Status Report

Slides:



Advertisements
Similar presentations
Type 2 Diabetes – An Overview
Advertisements

Diabetes and Heart Disease
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
STOPPING DIABETES STARTS NOW
Canadian Diabetes Association Clinical Practice Guidelines Dyslipidemia Chapter 24 G. B. John Mancini, Robert A. Hegele, Lawrence A. Leiter.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Managing Diabetes What Is Diabetes? and Diabetes ABCs.
COMMON LIFESTYLE DISEASES
DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.
Diabetes: What You Should Know.
DIABETES With All My Heart Presented by: Regina Weitzman, MD.
What is Diabetes?.
Health Screening. Should you go for health screening? Health screening helps to discover if a person is suffering from a particular disease or condition,
With Open Eyes Presented by: Regina Weitzman, MD.
DIABETES Power over Diabetes Presented by: Regina Weitzman, MD.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Better Health. No Hassles. Type 2 Diabetes. Better Health. No Hassles. TYPE 2 DIABETES Chronic condition that affects the way your body metabolizes sugar.
Mentoring in Medicine Virtual Camp Final project 22 nd August, 2013 By Poojitha Kolluri.
Diabetes
Diabetes Mellitus For high school and college students By Emily Freedman A disease that disrupts normal metabolism, interfering with cells’ ability to.
What the GP Should Know about Diabetes Mellitus Dr. Muhieddin Omar.
Diabetes Mellitus By: Jenna Pressler Sara Seidman Emily Freedman A disease that disrupts normal metabolism, interfering with cells’ ability to take in.
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
After eating, most food is turned into glucose, the body’s main source of energy. What Happens When We Eat? American Diabetes Association.
Categories of disease Genetic (born with – even if disease doesn’t develop till later in life) Infectious – Virus and bacterial Environmental / Self-inflicted.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Polypill x Aspirin Project Groups 3 and 4
 Provide a high level overview of diabetes head to toe.  Discuss the importance of keeping A1Cs under 8.  Identify ways to prevent long-term complications.
DIABETES by PAULINE ANSINE BSN. RN. WHAT IS DIABETES Diabetes is a serious lifelong condition that cannot be cured, but can be managed. With diabetes,
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Diabetes By: Angela Thomas.
Philip AJ Matt. Diabetes Mellitus Also called simply Diabetes, is a disease characterized by high blood glucose(Hyperglycemia) resulting from inadequate.
STOPPING DIABETES STARTS NOW
Control of Blood Sugar Diabetes Mellitus.
RISK FACTORS – CVD.
Diabetes Care Planning Interim Results
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Visfatin in Type 2 Diabetes Mellitus
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Nursing Care of Patients with Hypertension
At the end of this talk, the resident will be able to:
Non-Communicable Diseases Unit Lesson 3
Preventing Cardiovascular Disease
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
The Anglo Scandinavian Cardiac Outcomes Trial
Jessica johnson, pharm. D.
STOPPING DIABETES STARTS NOW
Diabetes Mellitus.
STOPPING DIABETES STARTS NOW
Chapter 10 Diet and Health
Screening and Monitoring
NUTRITION AND FITNESS LIFESYTLE CHANGE PROGRAM
Macrovascular Complications Microvascular Complications
Getting the Best Care for Your Diabetes
Type 2 diabetes: Overlap of clinical conditions
Rational Order of Laboratory Tests in Cardiovascular Diseases
Section overview: Cardiometabolic risk reduction
Goals & Guidelines A summary of international guidelines for CHD
STOPPING DIABETES STARTS NOW
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
Prepared by :Dr. Latifa Mari’e
Presentation transcript:

Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes Information from the Annual Indian Health Service Diabetes Audit Makah couple

Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was diagnosed predominately in patients age 40 and older. Today, young adults (30-35) are the fastest growing group of Type 2 Diabetes.

Type 1 Diabetes- Immune-mediated form of diabetes Type 1 Diabetes- Immune-mediated form of diabetes. The body produces no insulin at all due to islet cell destruction. Type 2 Diabetes-Caused by a combination of insulin resistance and insulin deficiency. Gestational Diabetes-Diabetes associated with pregnancy. Pre-Diabetes (also called Impaired Glucose Tolerance (IGT)-Pre-diabetic state marked by elevated blood sugar. People with IGT are at high risk for progression to Type 2 Diabetes.

Diabetes can be effectively treated and controlled. The duration of diabetes is related to complications such as kidney disease, cardio vascular disease, and amputation. Intensive treatment can reduce the risk of complications of diabetes.

Obesity and physical inactivity are associated with the development of Type 2 Diabetes. Adopting habits that control weight and increasing exercise has been shown to significantly reduce the risk of developing diabetes. Minimal weight loss of just 10-20 pounds can improve blood glucose, blood pressure, and cholesterol in patients with Type 2 Diabetes.

As a patient's Hemoglobin A1c (A1c) becomes elevated, the risk of complications increases. A1c estimates the average degree of glycemic control over a period of time. A1c should be monitored at 3-4 month intervals for those with elevated levels (HbA1C >7.0%).

The target Blood Pressure (BP) for patients with diabetes is < 130/85. High BP increases the risk of heart disease and renal failure in Type 2 Diabetes.

Tobacco abuse is the primary preventable risk for cardiovascular disease, which is the leading cause of death in diabetes.

Over time, smoking damages the blood vessels. When coupled with excessive glucose in the blood, the effect can be devastating.

Aspirin is used as a primary and secondary treatment strategy to prevent cardiovascular events, regardless of disease status. Men and women with diabetes have a 2-4 fold increase at risk of dying from complications of cardiovascular disease.

ACE Inhibitors are medications that prevent kidney damage and are prescribed to patients with diabetes. Treatment with ACE Inhibitors have been shown to delay the progression from Microalbuminuria to Proteinuria in patients with diabetes. Ace Inhibitors are commonly prescribed to patients with hypertension as well.

Optimal LDL cholesterol levels for adults with diabetes are <100 mg/dl. Pharmacological inter-vention is recommended if dietary and lifestyle changes are ineffective in lowering LDL to <100 mg/dl, or immediately if LDL >160 mg/dl People with diabetes may benefit significantly from statin therapy even if their LDL is below 100mg/dl.

Screening for foot problems, vision problems, and dental problems occur more frequently for patients with diabetes. Diabetics patients need these exams at least once a year.

Medical nutrition, therapy, and exercise are the primary treatment strategies for Type 2 Diabetes. All patients with diabetes and their families should have diabetes self-management education every year.

Diabetic patients should have a flu vaccine and pneumovax every year. Yearly re-vaccination for flu is recommended to provide up-to-date protection. The pneumovax vaccine is necessary at least once and may need a booster, according to physician discretion.

Protein appearing in the urine is an indication of kidney disease.

People with Type 2 Diabetes who have Microalbuminuria are more likely to have a heart attack or stroke. Treatment with ACE Inhibitors slows the deterioration of kidney function in diabetes.

Blood creatinine is a measure of renal function Blood creatinine is a measure of renal function. Patients with diabetes are at risk for renal disease. This test is to be performed annually.

Risk factors for Arteriosclerosis include: Total Cholesterol <200 LDL>100 HDL<40 in HDL<45 in women TG>200 A lipid panel should be performed annually (TC, LDL, HDL, TG).

All patients with LDL >100 require medical nutrition, therapy, and lifestyle modifications. Pharmacological intervention is recommended if dietary interventions and lifestyle modifications are ineffective in lowering LDL to less than 100.

Risk factors for arteriosclerosis include: Total Cholesterol <200 LDL>100 HDL<40 in HDL<45 in women TG>200 A lipid panel should be performed annually (TC, LDL, HDL, TG).

Risk factors for Arteriosclerosis include: Total Cholesterol <200 LDL>100 HDL<40 in HDL<45 in women TG>200 A lipid panel should be performed annually (TC, LDL, HDL, TG).

A baseline EKG should be obtained after diagnosis of diabetes A baseline EKG should be obtained after diagnosis of diabetes. This should be repeated every 1-5 years as clinically indicated. For those 40 years of age and above, or with diabetes duration of over 10 years, an EKG every 1-2 years is recommended.

Patients with diabetes are at risk for activation of latent Tuberculosis (TB) Infection (LBTI). There is a greater risk of progressing to active TB if not treated. Patients with diabetes should have a PPD if their TB status is unknown.

Self Monitoring Blood Glucose (SMBG) determines the pattern of blood glucose throughout the day. This pattern provides information for selection and adjustments in therapy.